Last Posted: Oct 17, 2018
- Ethical Considerations in Neurogenetic Testing.
Su Xiaowei W et al. Seminars in neurology 2018 Oct 38(5) 505-514
- Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Hart M Ragan et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Oct
- 1 in 38 individuals at risk of a dominant medically actionable disease.
Haer-Wigman Lonneke et al. European journal of human genetics : EJHG 2018 Oct
- Exploring neurologists' perspectives on the return of next generation sequencing results to their patients: a needed step in the development of guidelines.
Hurlimann Thierry et al. BMC medical ethics 2018 Sep 19(1) 81
- The importance of genetic counselling in genome-wide sequencing
AM Elliot et al, October 3, 2018
- Disclosure of Individual Research Results and Incidental Findings in Biobank Research: Why We Need an Evidence-based Approach.
Fleming Jennifer et al. Journal of law and medicine 24(1) 89-95
- Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
Faias Sandra et al. Digestive diseases and sciences 2018 63(9) 2351-2361
- Laboratory considerations for prenatal genetic testing.
Wou Karen et al. Seminars in perinatology 2018 Jul
- User Acceptability of Whole Exome Reproductive Carrier Testing for Consanguineous Couples in Australia.
Josephi-Taylor Sarah et al. Journal of genetic counseling 2018 Sep
- Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
Delanne J et al. European journal of medical genetics 2018 Aug
- CDC Information (1)
- CDC-Authored Publications (2)
- Epidemiologic Studies (13)
- Translation/Implementation Studies (94)
- Evidence Synthesis (9)
- Guidelines (12)
- Reviews/Commentaries (67)
- Tools/Methods (12)
- Ethical/Legal and Social Issues (37)
- AMD Weekly Clips (1)
- Grants Supporting Publications
- Genetic Testing (GTR)
- Genetic Disease (OMIM)
- PubMed Review
- PubMed Clinical Queries
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Mar 1, 2018
- Page last updated:Oct 19, 2018
- Content source: